Technical Analysis for 0I0X - Codexis Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 2.68 | -0.07% | 0.00 |
Earnings due: May 2
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | -0.07% | |
| Narrow Range Bar | Range Contraction | -0.07% | |
| Wide Bands | Range Expansion | -0.07% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | 1 day ago |
| Down 2% | 1 day ago |
| Down 1% | 1 day ago |
| Possible NR7 | 1 day ago |
| Down 3% | 3 days ago |
Get a Trading Sidekick!
Codexis Inc. Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Classification
Keywords: Enzymes Pharmaceutical Manufacturers Catalysis Human Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.87 |
| 52 Week Low | 1.47 |
| Average Volume | 15,396 |
| 200-Day Moving Average | 2.58 |
| 50-Day Moving Average | 3.29 |
| 20-Day Moving Average | 3.00 |
| 10-Day Moving Average | 2.78 |
| Average True Range | 0.18 |
| RSI (14) | 35.90 |
| ADX | 14.79 |
| +DI | 19.74 |
| -DI | 31.68 |
| Chandelier Exit (Long, 3 ATRs) | 3.18 |
| Chandelier Exit (Short, 3 ATRs) | 3.16 |
| Upper Bollinger Bands | 3.51 |
| Lower Bollinger Band | 2.50 |
| Percent B (%b) | 0.18 |
| BandWidth | 33.63 |
| MACD Line | -0.16 |
| MACD Signal Line | -0.14 |
| MACD Histogram | -0.0206 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.77 | ||||
| Resistance 3 (R3) | 2.76 | 2.72 | 2.75 | ||
| Resistance 2 (R2) | 2.72 | 2.70 | 2.72 | 2.75 | |
| Resistance 1 (R1) | 2.70 | 2.68 | 2.71 | 2.71 | 2.74 |
| Pivot Point | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 |
| Support 1 (S1) | 2.64 | 2.64 | 2.65 | 2.65 | 2.61 |
| Support 2 (S2) | 2.60 | 2.62 | 2.60 | 2.61 | |
| Support 3 (S3) | 2.58 | 2.60 | 2.60 | ||
| Support 4 (S4) | 2.59 |
